Prediction of fetal growth retardation in pregnant women with undifferentiated connective tissue dysplasia


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To create a mathematical model for the prediction of fetal growth retardation in patients with undifferentiated connective tissue dysplasia (USTD). Subject and methods. A prospective cohort study was conducted in 201 pregnant women. According to the Fenton percentile growth chart, all the patients were divided into two groups. A study group consisted of 63 women whose babies were rated to be in the 3 rd to 10 lh percentiles. A comparison group included 138 patients whose babies were assigned to the 10 th or more percentile range. The magnitude of dysplasia was determined by the modified growth chart. Results. The investigators determined the clinical and molecular genetic predictors of fetal growth retardation, such as the magnitude of USTD, threatened miscarriage in the second trimester, an exacerbation of chronic urinary tract diseases, and threatened preterm labor during ultrasound study, as well as VEGFA gene polymorphisms: -634 G>C and VEGFA: 936 C>T. Conclusion. A mathematical model including the clinical anamnestic and molecular genetic parameters was developed to predict fetal growth retardation in patients with USTD.

全文:

受限制的访问

作者简介

Natalya Kan

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: n_kan@oparina4.ru
PhD, MD, the chief physician

Elrad Amiraslanov

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: e_amiraslanov@oparina4.ru
scientific researcher, collaborator of the obstetric observation department

Victor Tyutyunnik

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: tioutiounnik@mail.ru
PhD, MD, the head of the obstetric observation department

Andrey Donnikov

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: a_donnikov@oparina4.ru
MD, senior scientific researcher, laboratory of molecular genetics, A

Nataliya Tyutyunnik

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: tysia07@bk.ru
resident

参考

  1. Кадурина Т.И., Горбунова В.Н. Современные представления о дисплазии соединительной ткани. Казанский медицинский журнал. 2007; 4: 10-7. [Kadurina T.I., Gorbunova V.N. Modern conceptions of connective tissue dysplasia. Kazan Medical Journal. 2007; 4: 10-7.]
  2. Торшин И.Ю., Громова О.А. Дисплазия соединительной ткани, клеточная биология и молекулярные механизмы воздействия магния. Русский медицинский журнал. 2008; 16(4): 230-8. [Torshin I.Y., Gromova O.A. Connective tissue dysplasia, cell biology and molecular mechanisms of action of magnesium. Russian Medical Journal. 2008; 16 (4): 230-8.]
  3. Смирнова М.Ю., Строев Ю.И., Ниаури Д.А., Шлыкова А.В. Недифференцированные дисплазии соединительной ткани и их значение в акушерско-гинекологической практике. Вестник Санкт-Петербургского университета. 2006; 11(4): 95-104. [Smirnova M.Yu., Stroev Yu.I., Niauri D.A., Shlykova A.V. Undifferentiated connective tissue dysplasia and its importance in obstetric practice. Bulletin of St. Petersburg University. 2006; 11 (4): 95-104.]
  4. Robinson C.J., Johnson D.D., Chang E.Y. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am. J. Obstet. Gynecol. 2006; 195: 255-9.
  5. Spinillo A., Beneventi F., Epis O., Montanari L. The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome. Am. J. Obstet. Gynecol. 2008; 199(Suppl. 6): 632e1-e6.
  6. Peaceman A., Ramsey-Goldman R. Autoimmune connective tissue disease in pregnancy. Glob. libr. women’s med.; 2008. doi: 10.3843/GL0WM.10167
  7. Макацария А.Д., Юдаева Л.С. Ведение беременности и родов у больных с мезенхимальными дисплазиями (синдромами Марфана, Элерса-Данло, Рендю-Ослера). М.: Триада-Х; 2005. 125 с. [Makatsariya A.D., Yudaeva L.S. Management of pregnancy and childbirth in patients with mesenchymal dysplasia (Marfan, Ehlers-Danlos, Randy-Rendu syndromes). M.: Triad-X; 2005. 125 p.]
  8. Клеменов А.В. Особенности течения беременности у женщин с недифференцированной дисплазией соединительной ткани. Проблемы репродукции. 2005; 4: 85-8. [Clemenov A.V. The course of pregnancy in women with undifferentiated connective tissue dysplasia. Problems of reproduction. 2005; 4: 85-8.]
  9. World Health Organization - 2006. Available at: http://www.who.int/ childgrowth/training/Interpreting.pdf
  10. Higuchi R. Using PCR to engineer DNA. In: Erlich H., ed. PCR Technology. Principles and applications for DNA amplification. New York: Stockton Press; 1989: 61-70.
  11. Bányász I., Bokodi G., Vásárhelyi B., Treszl A., Derzbach L., Szabó A. et al. Genetic polymorphisms for vascular endothelial growth factor in perinatal complications. Eur. Cytokine Netw. 2006; 17(4): 266-70.
  12. Han S.W., Kim G.W., Seo J.S., Kim S.J., Sa K.H., Park J.Y. et al. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford). 2004; 43(9): 1173-7.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2014
##common.cookie##